Myelomatose

The Hematology Podcast - Season 5

Les mer

IMROZ Study - Isa-VRd for patients with NDMM-TI

Les mer

Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-­dosing, long-­term outcome of weight-­based dosing

Les mer

Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis

Les mer